Trials involving Multiple Types of Cancer

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(Merck) MK-3475-587 / KEYNOTE 587A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab TrialTozer, Dr RichardOpen to recruitmentNCT03486873
(CCTG) IND.238A Phase II Study of Durvalumab Retreatment in Patients who Discontinued Prior Checkpoint Therapy Due to Immune Related ToxicityEllis, Dr PeterOpen to recruitmentNCT03847649
(HHS) CRUSSHStereotactic body radiotherapy (SBRT) boost following urgent 3D conformal radiotherapy in the treatment of metastatic epidural spinal cord compression (SCC): A phase I feasibility trialSchnarr, Dr KaraOpen to recruitmentNCT03529708
(Bold Therapeutics) BOLD-100-001 / TRIO039A Phase 1b Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid TumoursJuergens, Dr RosalynOpen to recruitmentNCT04421820
(Merck) MK-7902-005 / LEAP-005 / E7080-G000-224A Multicenter, Open-label Phase 2 Study of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) in Previously Treated Subjects with Selected Solid Tumors (LEAP-005)Hotte, Dr SebastienSuspended/On holdNCT03797326
(Tesaro) 4010-01-001 / GARNETA Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1
Monoclonal Antibody, in Patients with Advanced Solid Tumors
Reade, Dr ClareSuspended/On holdNCT02715284
(Astellas) 7465-CL-202 / EV-202 / AST 246014An Open-label, Multi-cohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid TumorsHotte, Dr SebastienSuspended/On holdNCT04225117
Download PDF